Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

IRINOTECAN HYDROCHLORIDE

IRINOTECAN HYDROCHLORIDE

Standard Dose
20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 090393 (ANDA).

Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 20MG/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2011-05-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 090393 (ANDA). Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE; INJECTION - 20MG/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2011-05-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.